WINNIPEG, MANITOBA -- (MARKET WIRE) -- May 28, 2007 -- Miraculins Inc. (TSX VENTURE: MOM), a biotechnology company engaged in the discovery and development of products for select cancers, announces the re-election of Dr. Albert Friesen, Dr. Phiet Bui, Dr. Jim Charlton, Mr. Peter de Visser and Mr. Ted Paetkau to the Company’s Board of Directors at today’s Annual General and Special Meeting of Shareholders.
